Peripheral Arterial Disease Trial, Recruiting (NCT06516315)

Peripheral Arterial Disease Trial, Recruiting NCT06516315 Sponsor: Fondation Hôpital Saint-Joseph Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06516315 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have symptoms of peripheral artery disease (reduced blood flow in the legs) that fall within a certain severity range, and whose doctor has recommended a procedure to reopen the blocked or narrowed artery from the inside
People who have a specific type of blockage or narrowing — classified as simple and short — in the main artery running down the thigh (called the superficial femoral artery)
People who are covered by a health insurance system
People who speak French
People who have given their free, informed, and clear verbal agreement to take part

Who may not be able to join:

People whose kidneys are not working well enough (specifically, where kidney filtration rate is below 30 ml/min)
People who are currently detained or imprisoned
People who are under a legal protection order granted by a court
People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maxime RAUX, Principal investigator, Fondation Hôpital Saint-Joseph

Phone: + 331 44127883

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06516315

Sponsor: Fondation Hôpital Saint-Joseph

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: + 331 44127883

More information: https://clinicaltrials.gov/study/NCT06516315

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have symptoms of peripheral artery disease (reduced blood flow in the legs) that fall within a certain severity range, and whose doctor has recommended a procedure to reopen the blocked or narrowed artery from the inside
People who have a specific type of blockage or narrowing — classified as simple and short — in the main artery running down the thigh (called the superficial femoral artery)
People who are covered by a health insurance system
People who speak French
People who have given their free, informed, and clear verbal agreement to take part

Who may not be able to join:

People whose kidneys are not working well enough (specifically, where kidney filtration rate is below 30 ml/min)
People who are currently detained or imprisoned
People who are under a legal protection order granted by a court
People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondation Hôpital Saint-Joseph

Registry

ClinicalTrials.gov

Start date

29 April 2024

Est. completion

24 April 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Preoperative systolic velocity peak and intraoperative QFR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov